RE-EVALUATION OF THERAPY OF ACUTE MYOCARDIAL INFARCTION.
D000925:Anticoagulants; D002561:Cerebrovascular Disorders; D003327:Coronary Disease; D003850:Deoxyribonuclease I; D004844:Epistaxis; D005341:Fibrinolysin; D006471:Gastrointestinal Hemorrhage; D006406:Hematoma; D006417:Hematuria; D006469:Hemoptysis; D006470:Hemorrhage; D006801:Humans; D007362:Intensive Care Units; D009203:Myocardial Infarction; D011655:Pulmonary Embolism; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013924:Thrombophlebitis
D000925:Anticoagulants; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
ANTICOAGULANTS; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; EPISTAXIS; FIBRINOLYSIN; HEMATOMA; HEMATURIA; HEMOPTYSIS; HEMORRHAGE, GASTROINTESTINAL; INTENSIVE CARE UNITS; MYOCARDIAL INFARCT; PULMONARY EMBOLISM; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS